Platelet-to-albumin Ratio is a Potential Biomarker for Predicting Diabetic Nephropathy in Patients with Type 2 Diabetes
Overview
Authors
Affiliations
To evaluate whether platelet-to-albumin ratio (PAR) can predict diabetic nephropathy (DN) in type 2 diabetes mellitus (T2DM). A total of 140 patients with T2DM and 40 healthy individuals were enrolled retrospectively. T2DM patients were divided into three groups based on the urinary albumin-to-creatinine ratio, PAR was compared and receiver operating characteristic curve was constructed to evaluate the predictive value of PAR in DN in T2DM. There was a significant increase of PAR in DN among T2DM patients and PAR was positively correlated with serum creatinine, retinol-conjugated protein and β-microglobulin. Moreover, PAR was a risk factor for DN in T2DM patients, which predicted DN in T2DM with high sensitivity and specificity. PAR can be a potential candidate to predict DN in T2DM.
Leng L, Shen J, Li L, Li J, Li X, Liu D Sci Rep. 2024; 14(1):27112.
PMID: 39511276 PMC: 11543822. DOI: 10.1038/s41598-024-78582-1.
Ma H, Chen J, Zhan X, Ao S, Deng J, Tang R BMC Nephrol. 2024; 25(1):365.
PMID: 39427118 PMC: 11490134. DOI: 10.1186/s12882-024-03792-8.
Sagi B, Vas T, Csiky B, Nagy J, Kovacs T J Clin Med. 2024; 13(4).
PMID: 38398303 PMC: 10889748. DOI: 10.3390/jcm13040991.